We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
(+15%)
Cap. Flow
+$3.7B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$3.4B |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$885M |
| 3 |
Tesla
TSLA
|
+$252M |
| 4 |
Amazon
AMZN
|
+$156M |
| 5 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$379M |
| 2 |
Sherwin-Williams
SHW
|
+$161M |
| 3 |
NVIDIA
NVDA
|
+$154M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$116M |
| 5 |
Boeing
BA
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Communication Services | 15.36% |
| 4 | Healthcare | 13.38% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Atmos Energy
ATO
$28.4B
| $23K | ﹤0.01% |
201
-244
| -55% | -$27.8K |
|
677
CareTrust REIT
CTRE
$9.55B
| $23K | ﹤0.01% |
1,194
+1,136
| +1,959% | +$22.2K |
|
678
Hasbro
HAS
$13.3B
| $23K | ﹤0.01% |
+420
| New | +$24K |
|
679
Leidos
LDOS
$17.5B
| $23K | ﹤0.01% |
245
-122
| -33% | -$11.8K |
|
680
Maravai LifeSciences
MRVI
$895M
| $23K | ﹤0.01% |
+1,620
| New | +$23.3K |
|
681
Seaboard Corp
SEB
$4.06B
| $23K | ﹤0.01% |
6
-5
| -45% | -$19.4K |
|
682
Synchrony
SYF
$25.4B
| $23K | ﹤0.01% |
+803
| New | +$27K |
|
683
Bunge Global
BG
$21.6B
| $22K | ﹤0.01% |
+228
| New | +$22.2K |
|
684
Copa Holdings
CPA
$5.58B
| $22K | ﹤0.01% |
235
+208
| +770% | +$18.9K |
|
685
Equifax
EFX
$21.3B
| $22K | ﹤0.01% |
+106
| New | +$22.1K |
|
686
Public Storage
PSA
$60.8B
| $22K | ﹤0.01% |
74
-717
| -91% | -$211K |
|
687
Robert Half
RHI
$4.37B
| $22K | ﹤0.01% |
268
+132
| +97% | +$10.5K |
|
688
Hewlett Packard
HPE
$72.4B
| $21K | ﹤0.01% |
1,318
-1,689
| -56% | -$26.5K |
|
689
Louisiana-Pacific
LPX
$5.2B
| $21K | ﹤0.01% |
+381
| New | +$23.3K |
|
690
Moderna
MRNA
$23.9B
| $21K | ﹤0.01% |
137
+87
| +174% | +$14.4K |
|
691
Corebridge Financial
CRBG
$15.4B
| $20K | ﹤0.01% |
+1,268
| New | +$24.8K |
|
692
Darling Ingredients
DAR
$9.99B
| $20K | ﹤0.01% |
346
+296
| +592% | +$18.6K |
|
|
HBI
693
DELISTED
Hanesbrands
HBI
| $20K | ﹤0.01% |
3,889
-80
| -2% | -$503 |
|
694
Jacobs Solutions
J
$17.2B
| $20K | ﹤0.01% |
+208
| New | +$20.8K |
|
695
Jabil
JBL
$35.3B
| $20K | ﹤0.01% |
+224
| New | +$18K |
|
696
Blue Owl Capital
OWL
$18.2B
| $20K | ﹤0.01% |
1,834
+1,668
| +1,005% | +$20K |
|
697
Ovintiv
OVV
$17.6B
| $20K | ﹤0.01% |
+543
| New | +$24K |
|
698
Penske Automotive Group
PAG
$14.2B
| $19K | ﹤0.01% |
+136
| New | +$18.1K |
|
699
U-Haul Holding Co Series N
UHAL.B
$12.6B
| $19K | ﹤0.01% |
+360
| New | +$20.4K |
|
700
Waters Corp
WAT
$40.4B
| $19K | ﹤0.01% |
+60
| New | +$19.4K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.
- Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
- Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
- Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
- Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
- Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
- Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
- Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.